Similar articles for PMID: 19925672

Year	Number of Results
1997	1
1999	2
2002	2
2004	6
2005	1
2006	8
2007	7
2008	11
2009	7
2010	9
2011	13
2012	10
2013	8
2014	5
2015	4
2016	6
2017	2
2018	2
2019	2
2020	4
2022	2
2024	0

1

Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.

Kaidanovich-Beilin O, Lipina TV, Takao K, van Eede M, Hattori S, Laliberté C, Khan M, Okamoto K, Chambers JW, Fletcher PJ, MacAulay K, Doble BW, Henkelman M, Miyakawa T, Roder J, Woodgett JR. Kaidanovich-Beilin O, et al. Mol Brain. 2009 Nov 19;2:35. doi: 10.1186/1756-6606-2-35. Mol Brain. 2009. PMID: 19925672 Free PMC article.

2

Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.

MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, Drucker DJ, Nagy A, Woodgett JR. MacAulay K, et al. Cell Metab. 2007 Oct;6(4):329-37. doi: 10.1016/j.cmet.2007.08.013. Cell Metab. 2007. PMID: 17908561 Free article.

3

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.

Capurro V, Lanfranco M, Summa M, Porceddu PF, Ciampoli M, Margaroli N, Durando L, Garrone B, Ombrato R, Tongiani S, Reggiani A. Capurro V, et al. Biomed Pharmacother. 2020 Aug;128:110249. doi: 10.1016/j.biopha.2020.110249. Epub 2020 May 26. Biomed Pharmacother. 2020. PMID: 32470749 Free article.

4

Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.

Patel S, Doble BW, MacAulay K, Sinclair EM, Drucker DJ, Woodgett JR. Patel S, et al. Mol Cell Biol. 2008 Oct;28(20):6314-28. doi: 10.1128/MCB.00763-08. Epub 2008 Aug 11. Mol Cell Biol. 2008. PMID: 18694957 Free PMC article.

5

Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain.

Yao HB, Shaw PC, Wong CC, Wan DC. Yao HB, et al. J Chem Neuroanat. 2002 May;23(4):291-7. doi: 10.1016/s0891-0618(02)00014-5. J Chem Neuroanat. 2002. PMID: 12048112

6

Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.

Bersudsky Y, Shaldubina A, Kozlovsky N, Woodgett JR, Agam G, Belmaker RH. Bersudsky Y, et al. Behav Pharmacol. 2008 May;19(3):217-24. doi: 10.1097/FBP.0b013e3282feb099. Behav Pharmacol. 2008. PMID: 18469539

7

Tissue-specific analysis of glycogen synthase kinase-3α (GSK-3α) in glucose metabolism: effect of strain variation.

Patel S, Macaulay K, Woodgett JR. Patel S, et al. PLoS One. 2011 Jan 6;6(1):e15845. doi: 10.1371/journal.pone.0015845. PLoS One. 2011. PMID: 21253590 Free PMC article.

8

Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

Hurtado DE, Molina-Porcel L, Carroll JC, Macdonald C, Aboagye AK, Trojanowski JQ, Lee VM. Hurtado DE, et al. J Neurosci. 2012 May 23;32(21):7392-402. doi: 10.1523/JNEUROSCI.0889-12.2012. J Neurosci. 2012. PMID: 22623685 Free PMC article.

9

Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3α/β dependent mechanism.

Russell JC, Kishimoto K, O'Driscoll C, Hossain MA. Russell JC, et al. Cell Signal. 2011 Apr;23(4):673-82. doi: 10.1016/j.cellsig.2010.11.021. Epub 2010 Dec 3. Cell Signal. 2011. PMID: 21130869 Free PMC article.

10

Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.

Zhai P, Gao S, Holle E, Yu X, Yatani A, Wagner T, Sadoshima J. Zhai P, et al. J Biol Chem. 2007 Nov 9;282(45):33181-91. doi: 10.1074/jbc.M705133200. Epub 2007 Sep 12. J Biol Chem. 2007. PMID: 17855351 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year